Phenotypic screening in the 21st century

In the genomic era of 1990s-2000s, pharmaceutical research moved to target-based drug discovery which enabled development of a number of small molecule drugs against a wide range of diseases. In many cases however, drugs that arose from genomics failed, questioning the validity of the targets and th...

Descripció completa

Dades bibliogràfiques

Autors principals:	Birgit T. Priest, Gul Erdemli
Format:	Online
Idioma:	anglès
Publicat:	Frontiers Media SA 2021
Matèries:	RM1-950 Q1-390 label-free technologies gene networks pathways Phenotypic screenning Drug Discovery Systems Biology target-based assays panomic data thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology
Accés en línia:	18720
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!